Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Intermittent subthalamic nucleus deep brain stimulation induces risk-aversive behavior in human subjects.

Patel SR, Herrington TM, Sheth SA, Mian M, Bick SK, Yang JC, Flaherty AW, Frank MJ, Widge AS, Dougherty D, Eskandar EN.

Elife. 2018 Sep 10;7. pii: e36460. doi: 10.7554/eLife.36460.

2.

Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss.

Hara JH, Zhang JA, Gandhi KR, Flaherty A, Barber W, Leung MA, Burgess LP.

Laryngoscope Investig Otolaryngol. 2018 Mar 25;3(2):73-77. doi: 10.1002/lio2.148. eCollection 2018 Apr.

3.

It is Electric! Electroconvulsive Therapy for Refractory Central Pain and Comorbid Psychiatric Disease.

Strand JJ, Warner LL, Kamdar MM, Flaherty AW, Jackson VA.

J Palliat Med. 2018 Feb;21(2):266-268. doi: 10.1089/jpm.2017.0344. Epub 2018 Jan 12.

PMID:
29327970
4.

PURLs: Does azithromycin have a role in cesarean sections?

Castelli G, Flaherty A, Jarrett JB.

J Fam Pract. 2017 Dec;66(12):762-764.

5.

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease.

Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Sapan CV, Eidelberg D, During MJ, Kaplitt MG, Feigin A.

JCI Insight. 2017 Apr 6;2(7):e90133. doi: 10.1172/jci.insight.90133.

6.

Preliminary Predictors of Initial Attendance, Symptom Burden, and Motor Subtype in a US Functional Neurological Disorders Clinic Population.

Perez DL, Young SS, King JN, Guarino AJ, Dworetzky BA, Flaherty A, Chemali Z, Caplan D, Dickerson BC.

Cogn Behav Neurol. 2016 Dec;29(4):197-205.

PMID:
27984257
7.

Cooperation in an Uncertain World: For the Maasai of East Africa, Need-Based Transfers Outperform Account-Keeping in Volatile Environments.

Aktipis A, de Aguiar R, Flaherty A, Iyer P, Sonkoi D, Cronk L.

Hum Ecol Interdiscip J. 2016;44:353-364. Epub 2016 May 3.

8.

Sudden Sensorineural Hearing Loss: Primary Care Update.

Leung MA, Flaherty A, Zhang JA, Hara J, Barber W, Burgess L.

Hawaii J Med Public Health. 2016 Jun;75(6):172-4. Review.

9.

Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.

Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, Selkoe DJ, Oakes D, Shoulson I, Dong X, Marek K, Zheng B, Ivinson A, Hyman BT, Growdon JH, Sudarsky LR, Schlossmacher MG, Ravina B, Scherzer CR.

Brain. 2015 Sep;138(Pt 9):2659-71. doi: 10.1093/brain/awv202. Epub 2015 Jul 28.

10.

Polyurethane-coated breast implants revisited: a 30-year follow-up.

Castel N, Soon-Sutton T, Deptula P, Flaherty A, Parsa FD.

Arch Plast Surg. 2015 Mar;42(2):186-93. doi: 10.5999/aps.2015.42.2.186. Epub 2015 Mar 16.

11.

Management of malignancy-related ascites.

Flaherty AM.

Oncol Nurs Forum. 2015 Jan;42(1):96-9. doi: 10.1188/15.ONF.96-99.

PMID:
25542326
12.

Carcinoid heart disease.

Flaherty AM.

Oncol Nurs Forum. 2014 Nov 1;41(6):687-91. doi: 10.1188/14.ONF.687-691.

PMID:
25355025
13.

Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.

Stocks MJ, Alcaraz L, Bailey A, Bonnert R, Cadogan E, Christie J, Dixon J, Connolly S, Cook A, Fisher A, Flaherty A, Humphries A, Ingall A, Jordan S, Lawson M, Mullen A, Nicholls D, Paine S, Pairaudeau G, Young A.

ACS Med Chem Lett. 2014 Feb 8;5(4):416-21. doi: 10.1021/ml4005232. eCollection 2014 Apr 10.

14.

Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experience.

Shetty AV, Matrana MR, Atkinson BJ, Flaherty AL, Jonasch E, Tannir NM.

Clin Genitourin Cancer. 2014 Oct;12(5):348-53. doi: 10.1016/j.clgc.2014.01.004. Epub 2014 Jan 18.

15.

Clinical prognostic factors associated with outcome in patients with renal cell cancer with prior tyrosine kinase inhibitors or immunotherapy treated with everolimus.

Amato RJ, Flaherty A, Zhang Y, Ouyang F, Mohlere V.

Urol Oncol. 2014 Apr;32(3):345-54. doi: 10.1016/j.urolonc.2013.09.008. Epub 2013 Dec 8.

PMID:
24321256
16.

Implications for human papillomavirus in penile cancer.

Flaherty A, Kim T, Giuliano A, Magliocco A, Hakky TS, Pagliaro LC, Spiess PE.

Urol Oncol. 2014 Jan;32(1):53.e1-8. doi: 10.1016/j.urolonc.2013.08.010. Epub 2013 Nov 13. Review.

PMID:
24239463
17.

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study.

Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, Gomperts SN, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Hyman BT, Sudarsky LR, Growdon JH, Scherzer CR.

Neurology. 2013 Oct 22;81(17):1531-7. doi: 10.1212/WNL.0b013e3182a95818. Epub 2013 Sep 25.

18.

Historical perspective on the progress of chemotherapy-induced nausea and vomiting treatment in oncology nursing forum.

Flaherty AM.

Oncol Nurs Forum. 2013 May 1;40(3):205-7. doi: 10.1188/13.ONF.205-207.

PMID:
23615133
19.

Studying task-related activity of individual neurons in the human brain.

Patel SR, Sheth SA, Martinez-Rubio C, Mian MK, Asaad WF, Gerrard JL, Kwon CS, Dougherty DD, Flaherty AW, Greenberg BD, Gale JT, Williams ZM, Eskandar EN.

Nat Protoc. 2013 May;8(5):949-57. doi: 10.1038/nprot.2013.050. Epub 2013 Apr 18.

PMID:
23598445
20.

Phase II study of everolimus in metastatic urothelial cancer.

Milowsky MI, Iyer G, Regazzi AM, Al-Ahmadie H, Gerst SR, Ostrovnaya I, Gellert LL, Kaplan R, Garcia-Grossman IR, Pendse D, Balar AV, Flaherty AM, Trout A, Solit DB, Bajorin DF.

BJU Int. 2013 Aug;112(4):462-70. doi: 10.1111/j.1464-410X.2012.11720.x. Epub 2013 Apr 3.

21.

Management of pancreatic exocrine insufficiency.

Braddick JA, Flaherty AM.

Oncol Nurs Forum. 2013 Mar;40(2):116-9. doi: 10.1188/13.ONF.116-119. No abstract available.

PMID:
23448736
22.

Management of diabetes and pancreatic cancer.

Flaherty AM.

Oncol Nurs Forum. 2012 Sep;39(5):440-3. doi: 10.1188/12.ONF.440-443. Review. No abstract available.

PMID:
22940508
23.

Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.

Amato RJ, Flaherty AL, Stepankiw M.

Clin Genitourin Cancer. 2012 Mar;10(1):26-31. doi: 10.1016/j.clgc.2011.11.002. Epub 2011 Dec 13.

PMID:
22169794
24.

Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.

Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, Ashourian P, Kan CG, Chang S, Santarlasci A, Swords KE, Ravina BM, Hayes MT, Sohur US, Wills AM, Flaherty AW, Unni VK, Hung AY, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Sudarsky LR, Growdon JH, Ivinson AJ, Hyman BT, Scherzer CR.

Mov Disord. 2011 Oct;26(12):2283-6. doi: 10.1002/mds.23934. Epub 2011 Sep 23.

25.

Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH; American Society of Clinical Oncology.

J Clin Oncol. 2011 Nov 1;29(31):4189-98. doi: 10.1200/JCO.2010.34.4614. Epub 2011 Sep 26. Review. Erratum in: J Clin Oncol. 2014 Jun 1;32(19):2117. Dosage error in article text.

26.

Temporary interruption of deep brain stimulation for Parkinson's disease during outpatient electroconvulsive therapy for major depression: a novel treatment strategy.

Ducharme S, Flaherty AW, Seiner SJ, Dougherty DD, Morales OG.

J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):194-7. doi: 10.1176/appi.neuropsych.23.2.194.

PMID:
21677249
27.

Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonists.

Stocks MJ, Alcaraz L, Bailey A, Bonnert R, Cadogan E, Christie J, Connolly S, Cook A, Fisher A, Flaherty A, Hill S, Humphries A, Ingall A, Jordan S, Lawson M, Mullen A, Nicholls D, Paine S, Pairaudeau G, St-Gallay S, Young A.

Bioorg Med Chem Lett. 2011 Jul 1;21(13):4027-31. doi: 10.1016/j.bmcl.2011.04.135. Epub 2011 May 20.

PMID:
21652207
28.

Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response.

Gallagher DJ, Al-Ahmadie H, Ostrovnaya I, Gerst SR, Regazzi A, Garcia-Grossman I, Riches J, Gounder SK, Flaherty AM, Trout A, Milowsky MI, Bajorin DF.

Eur Urol. 2011 Aug;60(2):344-9. doi: 10.1016/j.eururo.2011.05.034. Epub 2011 May 25.

PMID:
21645967
29.

Brain illness and creativity: mechanisms and treatment risks.

Flaherty AW.

Can J Psychiatry. 2011 Mar;56(3):132-43. Review.

PMID:
21443820
30.

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.

LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A.

Lancet Neurol. 2011 Apr;10(4):309-19. doi: 10.1016/S1474-4422(11)70039-4.

PMID:
21419704
31.

Ventral intermediate thalamic stimulation for monoclonal gammopathy-associated tremor: case report.

Shields DC, Flaherty AW, Eskandar EN, Williams ZM.

Neurosurgery. 2011 May;68(5):E1464-7. doi: 10.1227/NEU.0b013e3182124633.

PMID:
21311371
32.

A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole.

Brown HE, Flaherty AW, Goff DC, Freudenreich O.

Prim Care Companion CNS Disord. 2011;13(6). pii: PCC.11l01188. doi: 10.4088/PCC.11l01188. No abstract available.

33.

Phase II study of sunitinib in patients with metastatic urothelial cancer.

Gallagher DJ, Milowsky MI, Gerst SR, Ishill N, Riches J, Regazzi A, Boyle MG, Trout A, Flaherty AM, Bajorin DF.

J Clin Oncol. 2010 Mar 10;28(8):1373-9. doi: 10.1200/JCO.2009.25.3922. Epub 2010 Feb 8.

PMID:
20142593
34.

Over the rainbow: a case of traumatic brain injury.

Quinn DK, Flaherty AW, Herman JB, Kleinschmidt TL.

Harv Rev Psychiatry. 2010 Jan-Feb;18(1):56-66. doi: 10.3109/10673220903523953. No abstract available.

PMID:
20047461
35.

Prospective assessment of stereotactic ablative surgery for intractable major depression.

Shields DC, Asaad W, Eskandar EN, Jain FA, Cosgrove GR, Flaherty AW, Cassem EH, Price BH, Rauch SL, Dougherty DD.

Biol Psychiatry. 2008 Sep 15;64(6):449-54. doi: 10.1016/j.biopsych.2008.04.009. Epub 2008 May 16.

PMID:
18486107
36.

Playing doctor well.

Flaherty AW.

Neurology. 2008 Mar 11;70(11):826-7. doi: 10.1212/01.wnl.0000304744.73977.a2. No abstract available.

PMID:
18332340
37.

A brief proposal, 150 words.

Flaherty A.

Nature. 2007 Dec 20;450(7173):1156. No abstract available.

PMID:
18097375
38.

Microelectrode-guided deep brain stimulation for Tourette syndrome: within-subject comparison of different stimulation sites.

Shields DC, Cheng ML, Flaherty AW, Gale JT, Eskandar EN.

Stereotact Funct Neurosurg. 2008;86(2):87-91. Epub 2007 Dec 12.

PMID:
18073521
39.

Regioselectivity and mechanism of dihalocarbene addition to benzocyclopropene.

Khrapunovich M, Zelenova E, Seu L, Sabo AN, Flaherty A, Merrer DC.

J Org Chem. 2007 Sep 28;72(20):7574-80. Epub 2007 Sep 7.

PMID:
17824649
40.

From symphony to cacophony: pathophysiology of the human basal ganglia in Parkinson disease.

Gale JT, Amirnovin R, Williams ZM, Flaherty AW, Eskandar EN.

Neurosci Biobehav Rev. 2008;32(3):378-87. Epub 2007 Apr 26. Review.

PMID:
17466375
41.

The role of the basal ganglia in bimanual coordination.

Kraft E, Chen AW, Flaherty AW, Blood AJ, Kwong KK, Jenkins BG.

Brain Res. 2007 Jun 2;1151:62-73. Epub 2007 Feb 17.

PMID:
17448452
42.

Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-alpha release from human alveolar macrophages.

Ratcliffe MJ, Walding A, Shelton PA, Flaherty A, Dougall IG.

Eur Respir J. 2007 May;29(5):986-94. Epub 2007 Mar 1. Erratum in: Eur Respir J. 2007 Dec;30(6):1236.

43.

Frontotemporal and dopaminergic control of idea generation and creative drive.

Flaherty AW.

J Comp Neurol. 2005 Dec 5;493(1):147-53. Review.

44.

Palladium-catalyzed cross-coupling of B-benzyl-9-borabicyclo[3.3.1]nonane to furnish methylene-linked biaryls.

Flaherty A, Trunkfield A, Barton W.

Org Lett. 2005 Oct 27;7(22):4975-8.

PMID:
16235936
45.

Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report.

Flaherty AW, Williams ZM, Amirnovin R, Kasper E, Rauch SL, Cosgrove GR, Eskandar EN.

Neurosurgery. 2005 Oct;57(4 Suppl):E403; discussion E403.

PMID:
16234657
46.
47.

Basal ganglia activity remains elevated after movement in focal hand dystonia.

Blood AJ, Flaherty AW, Choi JK, Hochberg FH, Greve DN, Bonmassar G, Rosen BR, Jenkins BG.

Ann Neurol. 2004 May;55(5):744-8.

PMID:
15122718
48.

Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample.

Eskandar EN, Flaherty A, Cosgrove GR, Shinobu LA, Barker FG 2nd.

J Neurosurg. 2003 Nov;99(5):863-71.

PMID:
14609166
49.
50.

The aza-

Anderson JC, Flaherty A, Swarbrick ME.

J Org Chem. 2000 Dec 29;65(26):9152-6.

PMID:
11149863

Supplemental Content

Loading ...
Support Center